Analysis Supports Link Between AD, MDD Pathogenesis

June 19th 2021, 2:20pm


The analysis identified 4 genes that were driven by atopic dermatitis (AD) and which had significant expression changes in favor of MDD development.

Expert Panel Makes 7 Recommendations for Vaccinations for Children With AD Receiving Dupilumab

June 18th 2021, 4:18pm


A panel of health care professionals reviewed published literature to develop a recommendation guide to advise providers on best practices when considering vaccinations for children with atopic dermatitis (AD) on dupilumab.

AD Patients Most Satisfied With Group-Based Educational Sessions

June 9th 2021, 4:15pm


Patients with atopic dermatitis (AD) benefit from extensive patient education. A new report suggests group-based sessions are preferred to individual educational sessions or fun activities.

Study Explores Circulating Biomarker Profiles of Patients With Atopic Dermatitis

June 3rd 2021, 8:30pm


Existing research has focused on skin symptoms, but a new study looks for alterations in the blood associated with moderate-to-severe atopic dermatitis.

Dupilumab Improves Work Quality of Life in Patients With AD

May 25th 2021, 6:30pm


A new report shows work-related quality of life in general—and also in terms of physical and mental/emotional health—improved when patients began treatment for atopic dermatitis.

Dr Jonathan Silverberg Discusses What Future Research on AD in Children Should Include

May 21st 2021, 3:00pm


Now that racial and ethnic disparities of atopic dermatitis prevalence among children have been confirmed, the next step in research will be to discover the reasons why those disparities exist, said Jonathan Silverberg, MD, PhD, MPH.

Childhood AD Affects Educational Outcomes, New Analysis Finds

May 19th 2021, 4:00pm


Children with severe atopic dermatitis, in particular, were less likely than a control group to complete education at all levels, from basic compulsory education to postgraduate education.

Dr Jonathan Silverberg Sheds Light on the Shift in Comorbidities Associated With Atopic Dermatitis

May 14th 2021, 12:30pm


In order to properly help patients manage their disease, it is critical for clinicians to recognize the differences in prevalence, severity, and persistency of atopic dermatitis among different demographics, said Jonathan Silverberg, MD, PhD, MPH.

Asthma Exacerbations Declined Among Black and Hispanic Patients During COVID-19

May 12th 2021, 1:30pm


Asthma exacerbations among Black/African American and Hispanic/Latinx adults with moderate-to-severe asthma decreased by approximately 40% during the COVID-19 pandemic, particularly among individuals who worked outside the home and those without type 2 inflammation.

Evaluating Dupilumab for Placement in a Value-Based Health Plan

May 10th 2021, 5:45pm


Dupilumab is effective for atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, but a recent presentation noted the payer challenge in placing the biologic in an optimal tier.